Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Long intergenic non-protein coding RNA 1501 (LINC01501)** is a human long non-coding RNA gene transcribed as an RNA molecule but not translated into a protein[1][3]. It belongs to the class of long intergenic non-coding RNAs (lincRNAs), which are defined as autonomously transcribed RNA molecules longer than 200 nucleotides and located in genomic regions that do not overlap any annotated protein-coding genes[5]. LincRNAs are an abundant subclass within long non-coding RNAs, often functioning in various aspects of gene expression regulation such as chromatin modification, transcriptional control, and possibly enhancer-associated activity[5][7]. While many lincRNAs play roles in human disease, especially cancer, no specific biological function, disease association, or therapeutic targeting information is currently available for LINC01501 itself in major genomic or biomedical data resources[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1501 (LINC01501).